DermTech Stock Target Price and Analyst Consensus

DMTK Stock  USD 0.61  0.01  0.97%   
The current analyst and expert consensus on DermTech is Buy, with only one strong buy opinion. The current projected DermTech target price consensus is 5.10 with 4 analyst opinions. The most common way DermTech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview DermTech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on DermTech. We encourage you to use your own analysis of DermTech to validate this buy or sell advice. DermTech buy-or-sell recommendation module provides average expert sentiment on the projected DermTech target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on DermTech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.
Lowest Forecast
4.64
Highest Forecast
5.66
Target Price
5.1
At this time, DermTech's Gross Profit is quite stable compared to the past year. Gross Profit Margin is expected to rise to 0.03 this year, although the value of Pretax Profit Margin will most likely fall to (6.93). At this time, DermTech's Long Term Debt is quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 34.3 M this year, although the value of Retained Earnings are projected to rise to (402.7 M).
  
It's important to approach DermTech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize DermTech price targets

DermTech's stock target price is an estimate of its future price, usually made by analysts. Using DermTech's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at DermTech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if DermTech's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional DermTech Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of DermTech is a key component of DermTech valuation and have some predictive power on the future returns of a DermTech.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DermTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.626.27
Details
Intrinsic
Valuation
LowRealHigh
0.030.606.25
Details
Naive
Forecast
LowNextHigh
0.010.456.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.56-0.51-0.48
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DermTech. Your research has to be compared to or analyzed against DermTech's peers to derive any actionable benefits. When done correctly, DermTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DermTech.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock:
Check out Macroaxis Advice on DermTech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for DermTech Stock analysis

When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
The data published in DermTech's official financial statements usually reflect DermTech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DermTech. For example, before you start analyzing numbers published by DermTech accountants, it's critical to develop an understanding of what DermTech's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of DermTech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DermTech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DermTech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DermTech. Please utilize our Beneish M Score to check the likelihood of DermTech's management manipulating its earnings.